Will the Pandemic Fundamentally Change Dentistry or Not? (On-Demand)
This panel comprises representatives from dental practice, dental innovation and entrepreneurship, dental education, dental manufacturing, and dental support organizations (DSOs). The panelists will discuss what dentistry has done differently during the pandemic and how doing those things differently has changed what dentistry will be doing in the future.
Learning Objectives:
Steps to Complete Course:
Distributors may purchase multiple copies of packages to distribute to learners, and follow their progress. Bulk discounts are below.
| Quantity | Price per voucher |
|---|---|
| 1+ | $0.00 |
Dr. Jeremy Krell is a general dentist, as well as an experienced investor with a business background. He has raised rounds and generated returns for investors at ten companies, sold three, and acquired two more as a key operator. Jeremy oversaw strategic provider innovation and development at Oscar Health, a health insurance company that had an IPO in 2021. He also led provider and clinical growth initiatives at quip, a subscription oral health company, and has since built the Barchester Bay Group, a portfolio consisting of over thirty separate ventures. Jeremy is an angel investor and sits on the boards of several healthcare and dental startups. He has a fifteen-plus year proven track record with start-ups, multi-million dollar fundraises, and acquisitions.
Keith A. Mays, DDS, MS, PhD is the dean of the University of Minnesota School of Dentistry. Dr. Mays earned a Doctor of Dental Surgery from the University of Michigan School of Dentistry and a Master of Science and Certificate in Prosthodontics from the University of Iowa. He completed a Bachelor of Science degree at Morgan State University and earned a PhD at the University of Maryland. Dr. Mays has served as a member of the American Dental Education Association board of directors and has held numerous leadership roles with ADEA and the National Dental Association.
Mary Govoni is an internationally recognized speaker, author, and consultant, working with dental teams for over 40 years on clinical efficiency, infection prevention, ergonomics, and team communication.
Mary is a Certified OSHA Outreach Trainer and assists dental practice across the country in achieving compliance with regulatory requirements. Mary also is known for her practical approaches to implementing systems and protocols to enhance patient safety, privacy, and data security. Mary a past president of the American Dental Assistants Association, a member of the American Dental Hygienists Association, a member of the Organization for Safety Asepsis and Prevention, the Academy of Dental Management Consultants, and the Speaking and Consulting Network. She has published numerous articles in Dental Economics, The Dental Assistant Journal, RDH Magazine, Dentistry Today, Inside Dentistry, and many others.
Napoleon Monroe, the sole inventor of the mMed medication-telemanagement patents, has been involved in the successful commercialization of patents for decades.
He spent more than 20 years at Survival Technology (now a part of Pfizer), where he built up and managed its IP portfolio. There, he invented three medical devices that were patented and commercialized, two for auto-injectors and one for a transtelephonic peak-flow monitoring device.
Mr. Monroe also led teams that invented, prototyped, tested, commercialized and scaled up emergency pharmaceutical delivery systems, such as: the original EpiPen, for treatment of anaphylactic shock; the Antidote Treatment Nerve Agent Auto-Injector delivery system, which still protects U.S. and allied military and civilian personnel; and products that supported the formation of Shahal Medical Services in Israel (acquired by Shanghai Jiuchuan) and Raytel (now part of Philips in the U.S.)
Later, as vice president of corporate brand development for global healthcare distribution and service company Henry Schein, Inc., Mr. Monroe was responsible for all aspects of the company's private brands. He also began filing the patents that now comprise the mMed patent portfolio.
A subject matter expert in a variety of areas related to drug delivery and connected healthcare products, he has authored articles for such industry publications as ONdrugDELIVERY, PDA Letter, and PharmaVOICE. He also has moderated, presented, and participated in panels at numerous national and international events, including industry meetings with the Federal Drug Administration.
His expertise also includes licensing, regulatory processes as business opportunities, risk management and international marketing, with experience managing business relationships in more than 30 countries.
Dr. Ro is a proud graduate from the University of Illinois at Chicago (UIC) – College of Dentistry. In addition to his DDS degree, he also obtained a Master’s in Business Administration (MBA) from Loyola University with dual emphases in finance and marketing. He later capitalized on the opportunity to utilize all three when he purchased his first practice in the south suburbs of Chicago in 2008, where (despite a historically difficult period in the country’s economy) he led the practice on an exponential growth path from three employees operating in 650 square feet of space into a 25+ network of multi-specialty dental group practices with almost 100 dentists and dental specialists. In 2019, Dr. Ro founded the dental consulting firm DSO Strategy, LLC, which was created to help entrepreneurial dentists strategize a growth plan for their dental group practices that would transform each not only into a thriving DSO, but also an investable platform for institutional capital. He also served as a key advisor to multiple private-equity funds as well as banks.